Fintel reports that on September 13, 2023, Cantor Fitzgerald reiterated coverage of Intellia Therapeutics (NASDAQ:NTLA) with a Overweight recommendation.
Fintel reports that on September 13, 2023, JP Morgan maintained coverage of RTX (NYSE:RTX) with a Overweight recommendation. Analyst Price Forecast Suggests 35.94% Upside
Fintel reports that on September 13, 2023, Goldman Sachs maintained coverage of Ambrx Biopharma Inc - ADR (NYSE:AMAM) with a Neutral recommendation.
Fintel reports that on September 12, 2023, Cantor Fitzgerald reiterated coverage of Bicycle Therapeutics Plc - ADR (NASDAQ:BCYC) with a Overweight recommendation.
Fintel reports that on September 13, 2023, Needham maintained coverage of Rocket Pharmaceuticals (NASDAQ:RCKT) with a Buy recommendation. Analyst Price Forecast Suggests 250.90% Upside
Fintel reports that on September 13, 2023, Cantor Fitzgerald reiterated coverage of Biomarin Pharmaceutical Inc. - Registered Shares (NASDAQ:BMRN) with a Overweight recommendation.
Fintel reports that on September 13, 2023, BMO Capital maintained coverage of Casey`s General Stores (NASDAQ:CASY) with a Outperform recommendation.
Fintel reports that on September 13, 2023, HC Wainwright & Co. reiterated coverage of Alpine Immune Sciences (NASDAQ:ALPN) with a Buy recommendation.
Fintel reports that on September 13, 2023, Needham reiterated coverage of Alphabet Inc - (NASDAQ:GOOGL) with a Buy recommendation. Analyst Price Forecast Suggests 11.59% Upside
Fintel reports that on September 12, 2023, Truist Securities maintained coverage of Array Technologies (NASDAQ:ARRY) with a Buy recommendation. Analyst Price Forecast Suggests 20.22% Upside
Fintel reports that on September 13, 2023, HC Wainwright & Co. reiterated coverage of Mirum Pharmaceuticals (NASDAQ:MIRM) with a Buy recommendation.
Fintel reports that on September 13, 2023, TD Cowen initiated coverage of Lamb Weston Holdings (NYSE:LW) with a Outperform recommendation.